NOMAD POWER SOLUTIONS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- NOMAD POWER SOLUTIONS, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2023-12-31 was 0.00 shares.
- NOMAD POWER SOLUTIONS, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2023-09-30 was 0.00 shares.
- NOMAD POWER SOLUTIONS, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2023-06-30 was -11.25K shares.
- NOMAD POWER SOLUTIONS, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2023-03-31 was 12.50K shares.
- NOMAD POWER SOLUTIONS, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2023 was 1.25K shares.
- NOMAD POWER SOLUTIONS, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2021 was 208.33K shares.
- NOMAD POWER SOLUTIONS, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2018 was 20.00K shares.
- NOMAD POWER SOLUTIONS, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2012 was 100.00K shares, a 13.05% decline from fiscal 2011.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2023-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-24 | 1.25K shares 10-K · filed 2025-03-24 |
| 2023-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | |
| 2023-06-30 | -11.25K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | |
| 2023-03-31 | 12.50K shares 10-Q · filed 2023-05-10 | |
| 2021-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-29 | 208.33K shares 10-K · filed 2023-03-29 |
| 2021-09-30 | 83.33K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | |
| 2018-12-31 | 20.00K shares 10-K · filed 2020-03-25 | |
| 2012-12-31 | 200.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-15 | 100.00K shares 10-K · filed 2013-03-15 |
| 2012-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-13 | |
| 2011-12-31 | 115.02K shares 10-K · filed 2013-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B |